Catalyst Pharmaceutical Partners, Inc. (CPRX) - NASDAQ
From other sites
Company Description
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases. The company has three drug candidates in development: Firdapse, CPP-115 and CPP-109. The company was founded by McEnany J.... More
Sector: Healthcare
Industry: Drugs - Generic
Country: United States